Guangzhou, China

Xianxing Jiang

This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Jiang, Xianxing, Shenzhen Turier Biotech Co. Ltd.. Active years: 2019-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xianxing Jiang. Retrieved from https://idiyas.com/inventor/xianxing-jiang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Xianxing Jiang in Medical Therapeutics

Introduction

Xianxing Jiang, an accomplished inventor based in Guangzhou, China, has made significant contributions to the field of medical therapeutics. His innovative work primarily focuses on developing compounds aimed at treating metabolic diseases, showcasing his commitment to advancing healthcare solutions.

Latest Patents

Jiang holds two patents, highlighting his expertise in the pharmaceutical sector. His latest inventions include:

1. **GLP-1R/GCGR Dual Target Agonist Polypeptide for Treatment of Fatty Liver Diseases, Hyperlipemia, and Arteriosclerosis**: This invention describes polypeptide compounds that exhibit a dual target agonist effect on glucagon-like peptide-1 receptor (GLP-1R) and glucagon receptor (GCGR). These compounds are characterized by their high enzymolysis stability and biological activity, without adverse reactions. They are capable of managing abnormal triglycerides and cholesterol levels in the blood, reducing liver enzyme levels, and alleviating liver injury and fibrosis associated with non-alcoholic fatty liver diseases (NAFLDs), hyperlipemia, and arteriosclerosis.

2. **Oxyntomodulin Analogue**: This patent presents an oxyntomodulin analogue that possesses dual agonist activity for GCGR and GLP-1R. With enhanced enzymolysis stability and biological efficacy, this analogue shows great promise in developing medications for conditions such as hyperphagia, obesity, and diabetes.

Career Highlights

Xianxing Jiang’s career is marked by his innovative research and development efforts in biopharmaceuticals. He has worked with various companies, including Jiang, Xianxing, and Shenzhen Turier Biotech Co. Ltd., where he contributed his expertise to advance their therapeutic offerings significantly.

Collaborations

Throughout his career, Jiang has collaborated with notable individuals in the field, including Yuanwen Chen and Rui Wang. These partnerships have facilitated the exchange of ideas and collectively fostered advancements in medical therapeutics.

Conclusion

Xianxing Jiang stands out in the landscape of inventors due to his pioneering work in developing effective treatments for metabolic diseases. His patented innovations not only demonstrate his technical prowess but also reflect his dedication to improving patient outcomes in the realm of healthcare. As research progresses, the medical community eagerly anticipates the impact of his contributions on the future of therapeutic interventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…